Przemysław Pilaszek

FiLeClo

Przemysław Pilaszek has worked in the biotech industry for 27 years in the biotech industry. He co-founded TriMen Chemicals a CRO which collaborated with leading companies such as Exelixis, Corus Pharma, Takeda, ArQule, and Pfizer. He also co-founded startups Arendi and OncoArendi Therapeutics. As the founder of FiLeClo, he is driving a pipeline that includes an oncology drug and innovative molecules targeting bacteria (AMR), parasites, viruses, and obesity. Outside of science, he is a passionate beekeeper and an enthusiastic collector of 80s pop music on vinyl.